| CNPAX | GICPX | CNPAX / GICPX | |
| Total Expense Ratio | 0.74 | 0.90 | 82% |
| Annual Report Gross Expense Ratio | 0.74 | 1.47 | 50% |
| Fund Existence | 24 years | 33 years | - |
| Gain YTD | 4.921 | 3.943 | 125% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 250 | 1000 | 25% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 170B | 193M | 88,083% |
| Annual Yield % from dividends | 0.97 | 0.86 | 113% |
| Returns for 1 year | 6.66 | -4.48 | -149% |
| Returns for 3 years | 33.46 | 40.28 | 83% |
| Returns for 5 years | 12.85 | 14.33 | 90% |
| Returns for 10 years | 113.25 | 113.65 | 100% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| JUNZ | 35.21 | 0.63 | +1.81% |
| TrueShares Structured Outcome June ETF | |||
| ILCV | 105.27 | 0.31 | +0.30% |
| iShares Morningstar Value ETF | |||
| DDFF | 20.07 | 0.04 | +0.22% |
| Innovator Eq Dual Drctnl 15 Buf ETF™ Feb | |||
| CAPE | 32.78 | N/A | N/A |
| DoubleLine Shiller CAPE US Equities ETF | |||
| MSSM | 59.21 | -0.12 | -0.21% |
| Morgan Stanley Pathway Sm-Md Cp Eq ETF | |||